KOD Kodiak Sciences Inc

Price (delayed)

$129.01

Market cap

$5.78B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.32

Enterprise value

$5.55B

Sector: Healthcare
Industry: Biotechnology

Highlights

Kodiak Sciences's quick ratio has soared by 109% YoY but it has decreased by 22% from the previous quarter
Kodiak Sciences's net income has shrunk by 120% YoY and by 30% QoQ
The EPS has contracted by 25% from the previous quarter

Key stats

What are the main financial stats of KOD
Market
Shares outstanding
44.8M
Market cap
$5.78B
Enterprise value
$5.55B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
20.47
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$102.11M
EBITDA
-$99.49M
Free cash flow
-$69.71M
Per share
EPS
-$2.32
Free cash flow per share
-$1.54
Book value per share
$6.3
Revenue per share
$0
TBVPS
$10.65
Balance sheet
Total assets
$480.74M
Total liabilities
$198.96M
Debt
$77.32M
Equity
$281.78M
Working capital
$359.24M
Liquidity
Debt to equity
0.27
Current ratio
16.96
Quick ratio
17.39
Net debt/EBITDA
2.26
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-23.9%
Return on equity
-32.3%
Return on invested capital
-57%
Return on capital employed
-22.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KOD stock price

How has the Kodiak Sciences stock price performed over time
Intraday
6.55%
1 week
-1.85%
1 month
-11.58%
1 year
106.78%
YTD
-12.18%
QTD
-12.18%

Financial performance

How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$105.35M
Net income
-$102.13M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 149% YoY and by 29% from the previous quarter
Kodiak Sciences's net income has shrunk by 120% YoY and by 30% QoQ

Growth

What is Kodiak Sciences's growth rate over time

Valuation

What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
20.47
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 25% from the previous quarter
The stock's P/B is 162% above its last 4 quarters average of 7.8
The equity has declined by 9% since the previous quarter

Efficiency

How efficient is Kodiak Sciences business performance
KOD's ROIC has soared by 75% year-on-year and by 7% since the previous quarter
The ROA has soared by 58% YoY
KOD's return on equity is up by 48% year-on-year but it is down by 7% since the previous quarter

Dividends

What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KOD.

Financial health

How did Kodiak Sciences financials performed over time
The total assets is 142% greater than the total liabilities
Kodiak Sciences's quick ratio has soared by 109% YoY but it has decreased by 22% from the previous quarter
KOD's current ratio has surged by 103% year-on-year but it is down by 24% since the previous quarter
KOD's debt is 73% lower than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.